Institution
Guy's and St Thomas' NHS Foundation Trust
Healthcare•London, United Kingdom•
About: Guy's and St Thomas' NHS Foundation Trust is a healthcare organization based out in London, United Kingdom. It is known for research contribution in the topics: Population & Medicine. The organization has 7686 authors who have published 9631 publications receiving 399353 citations. The organization is also known as: Guy's and St Thomas' National Health Service Foundation Trust & Guy's and St Thomas' National Health Service Trust.
Topics: Population, Medicine, Randomized controlled trial, Cancer, Breast cancer
Papers published on a yearly basis
Papers
More filters
••
Copenhagen University Hospital1, Rigshospitalet2, Ege University3, Guy's and St Thomas' NHS Foundation Trust4, St George’s University Hospitals NHS Foundation Trust5, University of California, Los Angeles6, Royal Surrey County Hospital7, Tel Aviv University8, Ljubljana University Medical Centre9, Lund University10, Harvard University11, Royal Prince Alfred Hospital12, Netherlands Cancer Institute13, University of Sydney14, Augsburg College15, European Institute of Oncology16, University of Milan17, Derby Hospitals NHS Foundation Trust18, Institut Gustave Roussy19
TL;DR: The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination.
Abstract: The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, (8) use of dye, (9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination.
169 citations
••
Leiden University1, Radboud University Nijmegen2, Conwy & Denbighshire NHS Trust3, Boston Children's Hospital4, St Mary's Hospital5, University of Amsterdam6, Hamad Medical Corporation7, Instituto Gulbenkian de Ciência8, University of Ferrara9, Lille University of Science and Technology10, Northwick Park Hospital11, University of Manchester12, Princess Anne Hospital13, University of Genoa14, Churchill Hospital15, Charité16, Guy's and St Thomas' NHS Foundation Trust17, Maulana Azad Medical College18, Cedars-Sinai Medical Center19, Erasmus University Rotterdam20, Belfast Health and Social Care Trust21, Amrita Vishwa Vidyapeetham22, St. Michael's Hospital23, National Health Service24, Pompeu Fabra University25, University of Otago26, University of Bordeaux27, University of Turin28, Wrocław Medical University29, University of Southampton30, Istanbul University31, Utrecht University32, University College London33, Bezmialem Foundation University34
TL;DR: The emerging phenotype–genotype correlation is that SMARCB1 patients have the most marked physical phenotype and severe cognitive and growth delay, and the variability in phenotype seems most marked in ARIDs1A and ARID1B patients.
Abstract: De novo germline variants in several components of the SWI/SNF-like BAF complex can cause Coffin-Siris syndrome (CSS), Nicolaides-Baraitser syndrome (NCBRS), and nonsyndromic intellectual disability. We screened 63 patients with a clinical diagnosis of CSS for these genes (ARID1A, ARID1B, SMARCA2, SMARCA4, SMARCB1, and SMARCE1) and identified pathogenic variants in 45 (71%) patients. We found a high proportion of variants in ARID1B (68%). All four pathogenic variants in ARID1A appeared to be mosaic. By using all variants from the Exome Variant Server as test data, we were able to classify variants in ARID1A, ARID1B, and SMARCB1 reliably as being pathogenic or nonpathogenic. For SMARCA2, SMARCA4, and SMARCE1 several variants in the EVS remained unclassified, underlining the importance of parental testing. We have entered all variant and clinical information in LOVD-powered databases to facilitate further genotype-phenotype correlations, as these will become increasingly important because of the uptake of targeted and untargeted next generation sequencing in diagnostics. The emerging phenotype-genotype correlation is that SMARCB1 patients have the most marked physical phenotype and severe cognitive and growth delay. The variability in phenotype seems most marked in ARID1A and ARID1B patients. Distal limbs anomalies are most marked in ARID1A patients and least in SMARCB1 patients. Numbers are small however, and larger series are needed to confirm this correlation.
169 citations
••
TL;DR: Testicular cancer is increasing in incidence in many countries; however, mortality rates remain low and most men are cured.
Abstract: Background
Testicular cancer is a rare tumor type accounting for 1% of malignancies in men. It is, however, the most common cancer in young men in Western populations. The incidence of testicular cancer is increasing globally, although a decline in mortality rates has been reported in Western countries. It is important to identify whether the variations in trends observed between populations are linked to genetic or environmental factors.
168 citations
••
TL;DR: Pregnancies in women with HbSS genotype, compared with women without sickle cell disease, were at increased risk of maternal mortality, and meta-regression demonstrated that genotype (HbSS vs HbSC), low gross national income, and high study quality were associated with increased RRs.
168 citations
••
UCL Institute of Child Health1, University of Cambridge2, NHS Blood and Transplant3, University College London4, Birkbeck, University of London5, UCL Institute of Neurology6, Great Ormond Street Hospital7, Radboud University Nijmegen8, Hebrew University of Jerusalem9, Sahlgrenska University Hospital10, Southampton General Hospital11, Southmead Hospital12, Guy's and St Thomas' NHS Foundation Trust13, Belfast City Hospital14, University of Sydney15, Children's Hospital at Westmead16, Maastricht University17, Umeå University18, University of Birmingham19, Cardiff University20, University of Erlangen-Nuremberg21, University Medical Center Groningen22, Shaare Zedek Medical Center23, John Radcliffe Hospital24, University of Melbourne25, University of Duisburg-Essen26, University of Düsseldorf27, University of Barcelona28, Hospital Sant Joan de Déu Barcelona29, National Institutes of Health30
TL;DR: Heterozygous variants in the gene KMT2B are reported in 27 unrelated individuals with a complex progressive childhood-onset dystonia, often associated with a typical facial appearance and characteristic brain magnetic resonance imaging findings, and marked clinical benefit was observed following deep brain stimulation (DBS).
Abstract: Histone lysine methylation, mediated by mixed-lineage leukemia (MLL) proteins, is now known to be critical in the regulation of gene expression, genomic stability, cell cycle and nuclear architecture. Despite MLL proteins being postulated as essential for normal development, little is known about the specific functions of the different MLL lysine methyltransferases. Here we report heterozygous variants in the gene KMT2B (also known as MLL4) in 27 unrelated individuals with a complex progressive childhood-onset dystonia, often associated with a typical facial appearance and characteristic brain magnetic resonance imaging findings. Over time, the majority of affected individuals developed prominent cervical, cranial and laryngeal dystonia. Marked clinical benefit, including the restoration of independent ambulation in some cases, was observed following deep brain stimulation (DBS). These findings highlight a clinically recognizable and potentially treatable form of genetic dystonia, demonstrating the crucial role of KMT2B in the physiological control of voluntary movement.
168 citations
Authors
Showing all 7765 results
Name | H-index | Papers | Citations |
---|---|---|---|
Christopher J L Murray | 209 | 754 | 310329 |
Bruce M. Psaty | 181 | 1205 | 138244 |
Giuseppe Remuzzi | 172 | 1226 | 160440 |
Mika Kivimäki | 166 | 1515 | 141468 |
Simon I. Hay | 165 | 557 | 153307 |
Theo Vos | 156 | 502 | 186409 |
Ali H. Mokdad | 156 | 634 | 160599 |
Steven Williams | 144 | 1375 | 86712 |
Igor Rudan | 142 | 658 | 103659 |
Mohsen Naghavi | 139 | 381 | 169048 |
Christopher D.M. Fletcher | 138 | 674 | 82484 |
Martin McKee | 138 | 1732 | 125972 |
David A. Jackson | 136 | 1095 | 68352 |
Graham G. Giles | 136 | 1249 | 80038 |
Yang Liu | 129 | 2506 | 122380 |